Cargando…
Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at advanced sta...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047046/ https://www.ncbi.nlm.nih.gov/pubmed/33854147 http://dx.doi.org/10.1038/s41598-021-87525-z |